Expression kinetics of the (proto) oncogenes c-myc and bcl-2 following photodynamic treatment of normal and transformed human fibroblasts with 5-aminolaevulinic acid-stimulated endogenous protoporphyrin IX

Journal of Photochemistry and Photobiology B: Biology

Volumn 45, Issue 2-3, 1998, Pages 131-135

  Verwanger, Thomas ^a   Schnitzhofer, Gerlinde ^a   Krammer, Barbara ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Apoptosis; Gene expression; In vitro; Photodynamic; Quantitative RT PCR

Indexed keywords

AMINOLEVULINIC ACID; PROTEIN BCL 2; PROTOPORPHYRIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IRRADIATION; ONCOGENE C MYC; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMINOLEVULINIC ACID; CELL LINE; CELL LINE, TRANSFORMED; FIBROBLASTS; GENE EXPRESSION; HUMANS; KINETICS; PHOTOSENSITIZING AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; PROTOPORPHYRINS;

EID: 0032170754     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(98)00171-7     Document Type: Article

References (26)

1. [1] R.A. Weinberg, How cancer arises, Sci. Am. 275 (1996) 62-70.
2. [2] D. Fiedler, B. Krammer, P. Eckl, Cyto-and genotoxic potential of the photosensitizer Photosan 3 in the absence of light, J. Photochem. Photobiol. B: Biol. 22 (1994) 241-246.
3. [3] D. Fiedler, P. Eckl, P.B. Krammer, Does delta-aminolevolinic acid induce genotoxic effects?, J. Photochem. Photobiol. B: Biol. 33 (1) (1996) 39-45.
4. [4] G. Evan, T. Littlewood, D. Hancock, M. Bennett, E. Harrington, A. Fanidi, C-Myc: oncogene and tumour suppressor gene, in: E. Mihich, R.T. Schimke (Eds.), Apoptosis, Plenum, New York, 1994, pp. 63-84.
5. [5] M.C. Luna, S. Wong, C.J. Corner, Photodynamic therapy mediated induction of early response genes, Cancer Res. 54 (5) (1994) 1374-1380.
6. [6] G. Kick, G. Messer, G. Plewig, P. Kind, A.E. Goetz, Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy, Br. J. Cancer 74 (1996) 30-36.
7. [7] J. Yang, X.S. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J.Y. Cai, T.I. Peng, D.P. Jones, X.D. Wang, Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science 275 (1997) 1129-1132.
8. [8] R.M. Kluck, E. Bossywetzel, D.R. Green, D.D. Newmeyer, The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis, Science 275 (1997) 1132-1136.
9. [9] L.H. Boise, A.R. Gottschalk, J. Quintans, C.B. Thompson, Bcl-2 and Bcl-2-related proteins in apoptosis regulation, Curr. Top. Microbiol. Immunol. 200 (1995) 107-121.
10. [10] R. Hansen, M. Oren, p53; from inductive signal to cellular effect, Curr. Opin. Genet. Develop. 7 (1997) 46-51.
11. [11] J. He, M.L. Agarwal, H.E. Larkin, L.R. Friedman, L.-Y. Xue, N.L. Oleinick, The induction of partial resistance to photodynamic therapy by the protooncogene BCL-2, Photochem. Photobiol, 64 (5) (1996) 845-852.
12. [12] W. Meikrantz, R. Schlegel, Apoptosis and the cell cycle, J. Cell. Biochem. 58 (1995) 160-174.
13. [13] R.H. Scheuermann, S.R. Bauer, Polymerase chain reaction-based mRNA quantification using an internal standard: analysis of oncogene expression, Methods Enzymol. 218 (1993) 446-473.
14. [14] L.H. Hartwell, M.B. Kastan, Cell cycle control and cancer, Science 266 (1994) 1821-1828.
15. [15] R.C. Duke, D.M. Ojcius, J.D. Young, Cell suicide in health and disease, Sci. Am. 275 (6) (1996) 80-87.
16. [16] B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, J.D. Watson, Molekularbiologie der Zelle, VCH, Weinheim, 1995.
17. [17] S. Kumakura, H. Ishikura, H. Tsumara, Y. Iwata, J. Enod, S. Kobayashi, c-Myc and Bcl-2 protein expression during the induction of apoptosis and differentiation in TNFα-treated HL-60 cells, Leukemia and Lymphoma 23 (1996) 383-394.
18. [18] T.G. Cotter, M. Al-Rubeai, Cell death (apoptosis) in cell culture systems, TIBTECH 13 (1996) 150-155.
19. [19] K. Schulze-Osthoff, H. Walczak, W, Dröge, P.H. Krammer, Cell nucleus and DNA fragmentation are not required for apoptosis, J. Cell. Biol. 127 (1994) 15-20.
20. [20] V.P. Skulachev, Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxide-producing mitochondria and cell, FEBS Lett. 397 (1996) 7-10.
21. [21 ] Y. Luo, D. Kessel, Initiation of apoptosis versus necrosis by photodynamic therapy with chloroaluminum phthalocyanine, Photochem. Photobiol. 66 (4) (1997) 479-483.
22. [22] D. Kessel, Y. Lou, Mitochondrial photodamage and PDT-induced apoptosis, J. Photochem. Photobiol. B: Biol. 42 (2) (1998) 89-95.
23. [23] K.P. Überriegler, E. Banieghbal, B. Krammer, Subcellular damage kinetics within co-cultivated WI38/WI38-VA13-transformed human fibroblasts following δ-aminolevulinic-acid induced protoporphyrin-IX formation, Photochem. Photobiol. 62 (6) (1995) 1052-1057.
24. [24] Q. Peng, K. Berg, J. Moan, M. Kongshaug, J.M. Nesland, 5-Amino-levulinic acid-based photodynamic therapy: principles and experimental research, Photochem. Photobiol. 65 (2) (1997) 235-251.
25. [25] B. Krammer, K.P. Überriegler, In vitro investigations about ALA-induced protoporphyrin IX, J. Photochem. Photobiol. B: Biol. 36 (2) (1996) 121-126.
26. [26] D. Kessel, Y. Luo, Delayed oxidative photodamage induced by photodynamic therapy, Photochem. Photobiol. 64 (3) (1996) 601-604.